ArticleBMJ open2025

Genomic testing for bleeding disorders (GT4BD): protocol for a randomised controlled trial evaluating the introduction of whole genome sequencing early in the diagnostic pathway for patients with inherited bleeding disorders as compared with standard of care.

Megan Chaigneau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.